Артериальная ригидность и центральное давление: новые патофизиологические и лечебные концепции
https://doi.org/10.18705/1607-419X-2010--2-
Аннотация
Об авторах
Ж. Д. КобалаваРоссия
Ю. В. Котовская
Россия
Р. Е. Ахметов
Россия
Список литературы
1. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K. et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee // Circulation. - 2009. - Vol. 119, № 3. - P. 480-486.
2.
3. http://www.heartstats.org/latestadditions.asp?id=83
4.
5. Laurent S., Cockcroft J., Van Bortel L. et al. for the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications // Eur. Heart J.- 2006. - Vol. 27, № 21. - P. 2588 -2605.
6.
7. Nilsson P.M., Lurbe E., Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome [review] // J. Hypertens. - 2008. - Vol. 26, № 6. - P. 1049-1057.
8.
9. Nilsson P.M., Boutouyrie P., Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention // Hypertension.-2009. - Vol. 54, № 1.- P. 3-10
10.
11. Zethelius B., Berglund L., Sundstrom J. et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes // N. Engl. J. Med. - 2008. - Vol. 358, № 20. -P. 2107-2116.
12.
13. Wang T.J., Gona P., Larson M.G. et al. Multiple biomarkers for the prediction of first major cardiovascular events and death // N. Engl. J. Med. - 2006. - Vol. 355, № 25. - P. 2631-2639.
14.
15. Scuteri A., Najjar S.S., Morrell C.H. et al. Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events-the Cardiovascular Health Study // Diabetes Care. - 2005. - Vol. 28, № 4. - P. 882-887.
16.
17. Scuteri A., Najjar S.S., Muller D.C. et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness // J. Am. Coll. Cardiol. - 2004. -Vol. 43, № 8. -P. 1388-1395.
18.
19. Scuteri A., Tesauro M., Rizza S. et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome // Nutr. Metab. Cardiovasc. Dis. - 2008. - Vol. 18, № 5. - P. 349-356.
20.
21. Henskens L.H., Kroon A.A., van Oostenbrugge R.J. et al. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients // Hypertension. - 2008. - Vol. 52, № 6. - P. 1120-1126.
22.
23. Hanon O., Haulon S., Lenoir H. et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss // Stroke. - 2005. - Vol. 36, № 10. - P. 2193-2197.
24.
25. Scuteri A., Tesauro M., Appolloni S. et al. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual // J. Hypertens. - 2007. - Vol. 25, № 5. - P.1035-1040.
26.
27. Williams В., Lacy P.C. Central aortic pressure and clinical outcomes // J. Hypertens. - 2009. - Vol. 27, № 6. - P. 1123-1125.
28.
29. Agabiti-Rosei E., Mancia G., O'Rourke M.F. al. Central blood pressure measurements and antihypertensive therapy: a consensus document // Hypertension. - 2007. - Vol. 50, № 1. - P. 154-160.
30.
31. Boutouyrie P., Tropeano A.I., Asmar R. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study // Hypertension.- 2002. - Vol. 39, № 1. - P. 10-15.
32.
33. Mattace-Raso F.U., van der Cammen T.J., Hofman A. et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study // Circulation. - 2006. - Vol. 113, № 5. - P. 657-663.
34.
35. De Meyer T., Rietzschel E.R., De Buyzere M.L. et al. Studying telomeres in a longitudinal population-based study // Front. Biosci. - 2008. - Vol.13, № 1. - P. 2960-2970.
36.
37. Kuznetsova T., Brouilette S., Codd V. et al. Telomere attrition rate in a longitudinal population // J. Hypertens. - 2008. - Vol. 26 (Suppl. 1). - P. S132.
38.
39. Fuster J.J., Diez J., Andreґs V. Telomere dysfunction in hypertension // J. Hypertens. - 2007. - Vol. 25, № 11. - P. 2185-2192.
40.
41. Nordfjäll K., Eliasson M., Stegmayr B. et al. Telomere length is associated to obesity parameters but with a gender difference // Obesity (Silver Spring). - 2008. - Vol.16, № 12. - P. 2682-2689.
42.
43. Valdes A.M., Andrew T., Gardner J.P. al. Obesity, cigarette smoking, and telomere length in women // Lancet. - 2005. - Vol. 366, № 9486. - P. 662-664.
44.
45. Bekaert S., De Meyer T., Rietzschel E.R. et al. for the Asklepios Investigators. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease // Aging Cell. - 2007. - Vol. 6, № 5. - P. 639-647.
46.
47. Epel E.S., Merkin S.S., Cawthon R. et al. The rate if leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men: a novel demonstration // Aging. - 2009. - Vol. 1, № 1. - P. 81-88.
48.
49. Benetos A., Okuda K., Lajemi M. et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity // Hypertension. - 2001. - Vol. 37, № 2. - P. 381-385.
50.
51. Brouilette S.W., Moore J.S., McMahon A.D. et al. for the West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study // Lancet.- 2007. - Vol. 369, № 9556. - P. 107-114.
52.
53. Ornish D., Lin J., Daubenmier J. et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study // Lancet Oncol. - 2008. - Vol. 9, № 11. - P. 1048-1057.
54.
55. Guerin A.P., Blacher J., Pannier B. et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure // Circulation. - 2001. - Vol. 103, № 7. - P. 987-992.
56.
57. Laurent S., Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension: hypertension highlights // Hypertension. - 2007. - Vol. 49, № 6. - P. 1202-1206.
58.
59. Strazzullo P., Kerry S.M., Barbato A., Versiero M., D'Elia L., Cappuccio P.F. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials // Hypertension.- 2007. - Vol. 49, № 4. - P. 792-798.
60.
61. Williams B., Lacy P.S., Cruickshank J.K. et al. Impact of statin therapy on central aortic pressures and hemodynamics principal results of the conduit artery function evaluation - lipid-lowering arm (CAFE-LLA) study // Circulation. - 2009. - Vol. 119, № 1. - P. 53-61.
62.
63. Manisty С., Mayet J., Tapp R.J., Sever P.S. et al. ASCOT Investigators. Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) // Hypertension. - 2009. - Vol. 54, № 5. - P. 1009-1013.
64.
65. Staessen J., Bulpitt C.J., Fagard R., Lijnen P., Amery A. The influence of menopause on blood pressure // J Hum Hypertens. - 1989. - Vol. 3, № 6. - P. 427-433.
66.
67. Scuteri A., Bos A.J., Brant L.J. et al. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women // Ann Intern Med. - 2001. -Vol. 135, № 4. - P. 229-238.
68.
69. Angerer P., Kothny W., Stork S., von Schacky C. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial // J Am Coll Cardiol. - 2000. - Vol. 36, № 6. - P. 1789-1796.
70.
71. Hodis H.N., Mack W.J., Azen S.P. et al. for the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women // N. Engl. J. Med. - 2003. - Vol. 349, № 6. - P. 535-545.
72.
73. Teede H.J., Liang Y.L., Kotsopoulos D. et al. Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function // Climacteric. - 2002. - Vol. 5, № 2. - P. 160-169.
74.
75. Shargorodsky M., Boaz M., Luckish A. et al. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women // Atherosclerosis. - 2009. - Vol. 204, № 2. - P. 608-611.
76.
77. Kanis J.A., Burlet N., Cooper C. et al for the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women // Osteoporos. Int. - 2008. - Vol. 19, № 4. - P. 399-428.
78.
79. Herrmann K.L., McCulloch A.D., Omens J.H. Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy // Am. J. Physiol. Heart Circ. Physiol. - 2003. - Vol. 284, № 4. - P. 1277 - 1284.
80.
81. Wolffenbuttel B.H., Boulanger C.M., Crijns F.R. et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes // Proc Natl Acad Sci U S A. - 1998. - Vol. 95, № 8. - P. 4630-4634.
82.
83. Bolton W.K., Cattran D.C., Williams M.E. et al. for the ACTION I Investigator Group. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy // Am. J. Nephrol. - 2004. - Vol. 24, № 1. - P. 32-40.
84.
85. Kass D.A., Shapiro E.P., Kawaguchi M. et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker // Circulation. - 2001. - Vol. 104, № 13. - P. 1464-1470.
86.
87. Zieman S.J., Melenovsky V., Clattenburg L. et al. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension// J. Hypertens. - 2007. - Vol. 25, № 3. - P. 577-583.
88.
89. Tarkanyi I., Aradi J. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease // Biochimie. - 2008. - Vol. 90, № 1. - P. 156-172.
90.
91. Yang S.H., Qiao X., Fong L.G., Young S.G. Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation // Biochim. Biophys. Acta. - 2008. - Vol. 1781, № 10. - P. 36-39.
Рецензия
Для цитирования:
Кобалава Ж.Д., Котовская Ю.В., Ахметов Р.Е. Артериальная ригидность и центральное давление: новые патофизиологические и лечебные концепции. Артериальная гипертензия. 2010;16(2):126-133. https://doi.org/10.18705/1607-419X-2010--2-
For citation:
Kobalava Zh.D., Kotovskaya Yu.V., Akhmetov R.E. Arterial rigidity and central pressure: novel aspects of pathophysiology and therapy. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2010;16(2):126-133. (In Russ.) https://doi.org/10.18705/1607-419X-2010--2-